Techno Trends
Techno Trends
PEAK Surgical, Inc. launch a new tissue dissection device named PEAK PlasmaBlade TnA
PEAK Surgical, Inc. announced the launch of the PEAK((R)) PlasmaBlade TnA (Tonsil and Adenoid) tissue dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new product is indicated for cutting and coagulation of soft...
Techno Trends
Power of Micro in the Healthcare Industry – The benefits of Micro-Electro-Mechanical-Systems
With the increase in population, demand for healthcare products and services has also risen. The healthcare industry is adopting new technologies such as Micro-Electro-Mechanical-Systems (MEMS) to counter the increasing complexities it has been facing and to en-cash the advantage...
Techno Trends
Glenmark Pharmaceuticals Ltd. posted a net profit after tax of Rs 52.200 million
Glenmark Pharmaceuticals Ltd. posted a net profit after tax of Rs 52.200 million for the quarter ended June 30, 2009 The Company has posted a net profit after tax of Rs 52.200 million for the quarter ended June...
Techno Trends
Cell phone becomes a new medical device
Camera phone can capture far more than photos of people or pets at play.
Now the cell phones can play a vital role in annotated, organized, and transition of images to medical experts at major medical centers for analysis and...
Techno Trends
Apollo Hospitals Enterprise to post an Un-Audited profit of Rs
Apollo Hospitals Enterprise to post an Un-Audited profit of Rs. 448 million for the quarter ended June 30, 2009. On July 18th 2009, Apollo Hospitals Enterprise Ltd has announced the Un-Audited results for the quarter ended June...
Techno Trends
Digital IHC Solution, integrated image analysis for Breast Cancer introducted by Aperio Technologies
Aperio Technologies, Inc., a global leader in digital pathology for the healthcare and life sciences industry, is announced the launch of a digital pathology solution for Immunohistochemistry designed specifically for the clinical market. Aperio’s digital IHC solution is...
Techno Trends
Clarient launches new gene mutation test to help select therapy for non-small cell lung cancer
Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, announced the launch of a new gene mutation test that can help physicians select the proper therapy for patients with non-small...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
